Last reviewed · How we verify

NCT06016933

Effect of Spirulina on Periodontitis

Completed NA Last updated 30 August 2023
What this trial tests

NA trial testing spirulina gel in Periodontitis in 40 participants. Completed in 22 July 2023.

Timeline
1 July 2022
Primary endpoint
1 March 2023
22 July 2023

Quick facts

Lead sponsorKafrelsheikh University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 July 2022
Primary completion1 March 2023
Estimated completion22 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kafrelsheikh University

Who can join

Adults 35 to 50, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the clinical and immunological effect of spirulina in treatment of stage II periodontitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Unlocking the potential of microalgae-derived therapeutic carriers: Characteristics, types, and nanomedical applications.
    Wang P, Liu C, Zheng L. · · 2025 · cited 7× · PMID 40688659 · DOI 10.1016/j.mtbio.2025.102037

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Kafrelsheikh University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06016933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing